Group effectiveness Pfizer’s COVID vaccine effectiveness for children declines for Omicron Sara H. Byrd March 14, 2022
Group effectiveness Study shows vaccine efficacy against SARS-CoV-2 and severe disease in dialysis patients Sara H. Byrd March 11, 2022
Group effectiveness Efficacy Studies of KOVIR Capsule for Mild or Moderate COVID-19 Patients 100% of Mild or Moderate COVID-19 Patients Recover Completely Without Progressing to Later Stages of COVID Sara H. Byrd February 25, 2022
Group effectiveness Effectiveness of using a face mask or respirator in indoor public places for the prevention of SARS-CoV-2 infection Sara H. Byrd February 12, 2022
Group effectiveness Omicron has mutations detected in previous variants, which explains the vaccine’s effectiveness, scientists say Sara H. Byrd February 8, 2022
Group effectiveness Scientist misleads on efficacy and safety of COVID-19 vaccines for children Sara H. Byrd February 1, 2022
Group effectiveness Study Explores Efficacy of SARS-CoV-2 Variant Omicron Vaccine in Patients on Hemodialysis Sara H. Byrd January 28, 2022
Group effectiveness Comparative efficacy of BNT162b2 and mRNA-1273 vaccines in US veterans Sara H. Byrd January 13, 2022
Group effectiveness Field study confirms effectiveness of Pfizer vaccine in adolescents Sara H. Byrd January 12, 2022
Group effectiveness It’s time to include real efficacy data on drug labels Sara H. Byrd January 10, 2022
Group effectiveness Efficacy of previous infection in preventing re-infection with Omicron and other variants of SARS-CoV-2 in Qatar Sara H. Byrd January 10, 2022
Group effectiveness Demand for antibody cocktails soars and clogs hospitals, despite Omicron’s reduction in effectiveness Sara H. Byrd January 7, 2022
Group development Pan-Sarbecovirus Nanobodies May Improve Development of Superimmunity, Study Finds Sara H. Byrd January 4, 2022
Group effectiveness The efficacy of the 2-dose mRNA vaccine drops to 35% against omicron; boosters increase defense level – WHIO TV 7 and WHIO Radio Sara H. Byrd December 28, 2021
Group effectiveness Evaluating the effectiveness of early treatment of SARS-CoV-2 infection Sara H. Byrd December 17, 2021
Group effectiveness EMA examines new data on the effectiveness of Lagevrio (molnupiravir) for treating COVID-19 Sara H. Byrd December 15, 2021
Group effectiveness Effectiveness of COVID-19 booster vaccination strategies in partially vaccinated populations Sara H. Byrd December 13, 2021
Group effectiveness The first data of Sotrovimab show its effectiveness against the Omicron Covid variant: GSK-Vir Sara H. Byrd December 8, 2021
Group effectiveness Rapid test identifies efficacy of antibodies against COVID-19 variants Sara H. Byrd December 4, 2021
Group effectiveness Efficacy of COVID-19 vaccination in patients after allogeneic hematopoietic cell transplantation: what protection do we get? – Sengsayadeth – – British Journal of Hematology Sara H. Byrd December 2, 2021
Group effectiveness NRx Pharmaceuticals Notes New Data on the Efficacy of BriLife® COVID-19 Vaccine Against Delta … | national Sara H. Byrd November 26, 2021
Group activities Maine Principals’ Association publishes winter guidelines for athletics and activities Sara H. Byrd November 19, 2021
Group effectiveness Vaccine efficacy of the third dose of BNT162b2 against COVID-19 Sara H. Byrd November 8, 2021 0
Group effectiveness Largest real-world study evaluates effectiveness of third ‘booster’ dose of COVID-19 vaccine Sara H. Byrd October 31, 2021 0
Group effectiveness Effectiveness of BNT162b2 COVID-19 mRNA vaccine in immunocompromised people Sara H. Byrd October 26, 2021 0
Group effectiveness Study Examines Effectiveness of BNT162b2 Vaccine Against Delta Variant In Adolescents Sara H. Byrd October 22, 2021 0
:quality(70)/d1hfln2sfez66z.cloudfront.net/12-22-2021/t_bdaba60636af45e5a09119e76704e101_name_Omicron_projected_to_cause_more_COVID19__61c3848eb62da63ecbd85b51_1_Dec_22_2021_21_44_11_poster.jpg)
